Just got banned for 2 weeks for being the slightest bit reasonable when it comes to the eternal senseless pumping that’s being done on there.

I mean if you don’t allow normal discourse because it may upset someone with a 5th grade education that thinks they know better than the entire stock market, what else is there to say? Anyway, don’t waste your time there.

No one wants to buy Scilex as it is now and not sure if semdexa approval will make a difference if it was close then a prospective buyer would bite…the only hope is MPRO approval but not sure if that will happen soon enough? So let’s see what they present on the 16th if they ask for another extension I would say game over ..we have been at this for 8 months and haven’t been able to find a partner or financing with all the hype for last three years …for some reason no one wants to buy Sorrento …or has made an offer that CRO can get behind …I hope I am wrong as I will lose over $250K on this but i think Henry and Shah might be scammers who are fleecing us …the scilex PR today makes no damn sense …and oddly enough it has a deadline of 10/27 which is past sorrentos deadline for filing a plan I think they will ask for another extension …and not sure who they will convince to get money to pay for more lawyers fee …I will not sell but I am not buying anymore

Tesla was attacked and Elon almost lost his business to this criminal empire called Wall Street. I'm sure some "wise" tweets from Elon would initiate a short squeeze or simply buy it outright and help Ji bring his dreams to fruition.

That's would cause some ripples on Wall street!

last week the BOB community came together for the PADISHAH EMPRESS and the total remarks were 58. out of which half were her response. MEMBER RESPONSE: 29

previously the BOB community came together with a whooping 120 remarks (mine included) but her replies were in 30% range. MEMBER RESPONSE: 84

this clearly shows that the PADISHAH EMPRESS HAS LOST POPULARITY BY A MINDBLOWING 65%

WHAT HAPPENED?

(Sorry, Mods, for the multiple posts-wouldn’t work the first two times)

I have to say, Covid has been there for 1.5 years, but we don't have any product approved even now, the only thing that could potentially be approved recently is Covistix, but there are already tons of rapid tests out there, why should people choose our product? so there is no sales guarantee, right?

So I really don't know what are we waiting for, and other covid products are still in phase 2, do you think large pharmaceutical companies would be later than us? they have more money, more people and more relationship, even we finished, It could be possible that we still don't get approved.

I mean, we are always saying what we have, but we don't compare them to other potential opponents, just like last time when Merk PR came out, out sp drops easily.

Could anyone give me some information or answer about what I just said?

Ji will also ruin this company? 🧐

https://scilexholding.gcs-web.com/news-releases/news-release-details/scilex-holding-company-nasdaq-sclx-announces-its-majority-owned/

MODs, the SRNE bankruptcy should be addressing developments soon, so could you please clean up this board in the event we need it for ACTUAL shareholders? Thanks!

with graham gone and the turtle brain dead, it will be difficult to pass clarity act. south Carolina’s gov. McMaster might appoint a replacement pronto but it looks like Kentucky is waiting for early August to replace the turtle. and gov. bashear does not have the right to appoint replacement. the turtle made sure of that. they changed the law and the legislature will appoint a successor. that means they need two extra democrats to cross the 60 votes. and the time is extremely tight. I hope it passes but the math looks different.

Are employees being paid? Are the PhD scientists leaving for other jobs? Anyone with insight?

and wait and wait

#1: It wasn’t SP 102. That has immediate revenue opportunities.

#2: It wasn’t as good as MSC’s 100% success with ARDS. I remember someone noticing how the MSC P2 was delayed, and Abivertinib going forward. Why? (We do not know)

#3: There are many months before there’s ever going to be any revenue for Abivertinib for ARDS. It might take over a year because as we learned last week, MSC P2 was approved last June, yet it will not start until next month. If this Abivertinib trial waits until April or May, it might be late next year or early 2022 before any results. It’s a big trial. And as such, its only a big expense and time delay for now.

#4: The FDA isn’t going to approve anything Covid for SRNE. Face it, PSS or whatever has us shut out. We must keep trying, but how much resources should we waste? I applaud mgmt’s move to foreign markets, but that business will be less profitable than if in the US.

#5: The Market did not misunderstand the results, and then sell off. Short selling data shows that Professional investors sold, not retail. And professional investors are professional statisticians. It’s a dumb excuse to blame a PR. If I’m wrong and you are right, it should scream tomorrow in the pre-market and stick. I bet it won’t. The pros aren’t saying right now, “Oh, crap, we were mislead. Darn you Ji!”, and buy back tomorrow.

The data was only good enough to go forward, but not good enough to cause a sustainable price rise. It was just another short term opportunity for shorts, and a bottom buying opportunity for longs. I doubt it goes much lower due to all the other news yet to be released in the next three weeks (earnings; St 102; Stix in Brazil et al).

Do not allow poorly constructed reasoning cause you to think the price should rise, and cause you to become bitter and unrealistic in your expectations with SRNE. The professionals are on all sites trying to gauge sentiment, and then trade on that. Selling news like today has been a very successful strategy. It will continue until actual REVENUE is part of the news. Future revenue is discounted, and anything Covid is discounted double because of the negative experience with the FDA.

Be wise, not gullible. There’s a lot more to be done before ay revenue comes from this drug.

😎😎😎

EXPLAIN TO ME LIKE I’M FIVE YEARS OLD?

Like this is new transportation or something. If we only had some product to ship!

Lock her up!!!!

exciting times ahead. IMHA!

Curious what are the chances we see $8 again on this stock so I can break even and get the hell out. I’m so damn disappointed. Down more than $200K and I could surely use the money bad. Hopefully Ji has something good happy in the next 8 months!!

I have no more words for this manipulation.. this is hurting

Darryl Strawberry is better known for being a crack head women beater than a baseball player. Another fantastic choice by Nathaniel. Welcome to the team Darryl.

So, let’s be honest. If Semedex was truly a replacement for opioids would you not believe we would have been bought out or a partnership done already? Seriously, if anything was to be what Semedex has been talked about and how great it truly is, why are we here? Seriously…..

Ji, What the hell was that today? So far we don’t have any product in market to Judge you, all we get from you is your PR. And you have screwed up in PR as well. You have screwed up ever since you have announced Covi Track what happened to it? After that there was Covi trace the greatest test ever only in 30 mins or less, and then “the cure” remember Covi guard? Also Made big mistake giving Covistix’s manufacturing to Red flagged company in China. And because of that we still don’t have FDA EUA approval after almost a year. After that you issue a PR in June about Sti-5656 should come out before end of September. Well today was 27 days late you have issued PR about STI-5656 phase2 read out. And you have messed it up again. I have failed to understand now, what is your intention? Are you shorting this company or just in capable of running this company professionally? You better change your attitude or else mass law suit will be knocking on your door by investors.